ClinicalTrials.gg
Active, not recruitingNCT06720402Updated Dec 6, 2024

Pediatricians and Family Physicians Knowledge and Awareness on Sun Protection

An interventional study of Sun protection knowledge in Sun Protection, Skin Burn and Sunburn, sponsored by Marmara University. Active, not recruiting at 1 site in Turkey. Open to participants aged 24 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-06.

Sponsored by Marmara University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 10 months ago, but the record still lists the study as active, not recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
230
Allocation
Non-randomized
Ages
24 Years to 65 Years
Sex
All
01

Study summary

Sunlight has very important effects on the body. In addition to its positive effects such as regulation of circadian rhythm, synthesis of vitamin D and regulation of mood, it also has negative effects on the skin such as sunburn, hyperpigmentation, photoaging and skin cancer formation. These negative effects are known to be caused by ultraviolet (UV) (10 to 400 nm) rays of sunlight.

It is known that skin cancers such as melanoma, basal cell carcinoma and squamous cell carcinoma may develop in adults as a result of excessive exposure to UV rays. It has been shown that the development of skin cancer is rare in childhood.

Although skin cancers are not common in the pediatric age group, exposure to UV rays is higher than in adults. It is known that this cumulative exposure that develops over time may lead to the development of skin cancer in later ages. Therefore, it is argued that effective protection from UV rays is important in the pediatric age group. Guidelines emphasize the importance of preventive counseling in early childhood for reasons such as high sun exposure in the pediatric age group, increase in cumulative exposure with advancing age, prevention of the known adverse effects of sun rays with simple precautions, application of sun protection trainings given to the child for the rest of his/her life and thus decreasing the incidence of skin cancers. The World Health Organization and the American Academy of Pediatrics emphasize the following 5 basic points about reducing UV exposure in early childhood:

  • Avoid going outside between 10.00-15.00 when the sun is at its peak,
  • Usage of broad spectrum sunscreen children over 6 months,
  • Using a hat, clothing that fully protects the body, sunglasses, umbrellas when going outside,
  • When spending time outdoors, spend more time in shaded areas,
  • Avoidance of indoor tanning.

In this sense, it is of critical importance that all physicians have the necessary knowledge and equipment to provide preventive counseling on the negative effects of sunlight on the skin and cancer development.

In this study, it is aimed to investigate the knowledge levels of Pediatricians and Family Physicians about sun protection and to increase their knowledge and awareness levels about sun protection in order to provide preventive counseling for the pediatric age group and their families.

Read the detailed description

Sunlight has very important effects on the body. In addition to its positive effects such as regulation of circadian rhythm, synthesis of vitamin D and regulation of mood, it also has negative effects on the skin such as sunburn, hyperpigmentation, photoaging and skin cancer formation. These negative effects are known to be caused by ultraviolet (UV) (10 to 400 nm) rays of sunlight.

UV waves reaching the Earth are divided into three as Ultraviolet A (UV-A), Ultraviolet B (UV-B) and Ultraviolet C (UV-C). Approximately 95% of the UV rays reaching the Earth's surface are UV-A (320 to 400 nm). UV-A is known to contribute to photoaging, play an important role in hyperpigmentation and cause the development of skin cancer. UV-B (290 to 320 nm) constitutes 5% of UV radiation and contains the most biologically active wavelengths. UV-B is known to cause sunburn, inflammation, hyperpigmentation and skin cancer development. It is known that UV-C (200 to 290 nm) cannot reach the earth due to the ozone layer.

It is known that skin cancers such as melanoma, basal cell carcinoma and squamous cell carcinoma may develop in adults as a result of excessive exposure to UV rays. It has been shown that the development of skin cancer is rarer in childhood. It has been found that approximately 324 thousand patients worldwide are diagnosed with melanoma and 1.2 million patients are diagnosed with non-melanoma skin cancer each year. In Turkey, according to the latest data, 1477 patients were diagnosed with melanoma and 20,220 patients were diagnosed with non-melanoma skin cancer. According to Fitzpatrick skin classification, studies have found that the risk of cancer development is higher in light-skinned skin, while the risk of cancer development is lower in dark-skinned skin.

Although skin cancers are not common in the pediatric age group, exposure to UV rays is higher than in adults. It is known that this cumulative exposure that develops over time may lead to the development of skin cancer in later ages. Therefore, it is argued that effective protection from UV rays is important in the pediatric age group. Guidelines emphasize the importance of preventive counseling in early childhood for reasons such as high sun exposure in the pediatric age group, increase in cumulative exposure with advancing age, prevention of the known adverse effects of sun rays with simple precautions, application of sun protection trainings given to the child for the rest of his/her life and thus decreasing the incidence of skin cancers. The World Health Organization and the American Academy of Pediatrics emphasize the following 5 basic points about reducing UV exposure in early childhood:

  • Avoid going outside between 10.00-15.00 when the sun is at its peak,
  • Usage of broad spectrum sunscreen children over 6 months,
  • Using a hat, clothing that fully protects the body, sunglasses, umbrellas when going outside,
  • When spending time outdoors, spend more time in shaded areas,
  • Avoidance of indoor tanning.

In this sense, it is of critical importance that all physicians have the necessary knowledge and equipment to provide preventive counseling on the negative effects of sunlight on the skin and cancer development. In our country, it is known that Family Physicians working in the first step and Pediatricians working in fields take part in the provision of early childhood preventive health services. However, it is seen in the literature that both Pediatricians and Family Physicians do not have sufficient knowledge about sun protection methods and preventive counseling on this subject needs to be emphasized more in medical education.

In this study, it is aimed to investigate the knowledge levels of Pediatricians and Family Physicians about sun protection and to increase their knowledge and awareness levels about sun protection in order to provide preventive counseling for the pediatric age group and their families.

All participants will participate in a presentation about sun protection. Also motivational interviewing methods organized by a team of professionals in the field will be used in the planning and implementation of the presentation.

The training will be prepared as a presentation. The presentation will last at least 30 minutes. It will be conducted using Microsoft Powerpoint presentation, face to face as a group and motivational interviewing techniques will be implemented during session. Presentation will include the current recommendations of the American Academy of Pediatrics and the World Health Organization and will be prepared using appropriate data and visuals. The training content consists of 4 main topics:

  1. Purpose of the training program,
  2. Skin properties and functions,
  3. Sun rays, positive and negative effects of sun rays and skin diseases caused by sun rays,
  4. The importance of providing preventive counseling on sun protection and information on sun protection methods outlined by the American Academy of Pediatrics and the World Health Organization.

The knowledge level will be assessed by Skin Cancer and Sun Knowledge scale immediately before and after the program and at the 3th month.

02

Conditions studied

  • Sun Protection
  • Skin Burn
  • Sunburn

Browse trials for

Keywords

  • sun protection
  • children
  • pediatrician
  • family physician
  • preventative counseling
03

In context

Paresthesia

66 studies on the registry are indexed under Paresthesia; 14 are open to participants now.

This study's planned enrollment of 230 is above the median of 48 across 52 interventional studies indexed under Paresthesia.

Browse Paresthesia studies →

Lead sponsor

Marmara University is the lead sponsor of 599 studies on the registry; 138 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
24 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pediatrics residents and specialists
  • Family medicine residents and specialists
  • Family physicians working at family medicine centers

Exclusion criteria

Exclusion Criteria:

  • Medical students
  • Physicians working at other fields
  • Attendants who have skin cancer history at him/herself and in family
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
230 participants (estimated)

Study arms

  • Active comparator
    Pediatricians

    The group which consist of pediatricians.

    Behavioral: Sun protection knowledge

  • Active comparator
    Family physicians

    The group which consist of family physicians.

    Behavioral: Sun protection knowledge

Interventions

  • BehavioralSun protection knowledge

    To increase knowledge and awareness about sun protection methods, a presentation will be implented to pediatricians and family physicians.

06

What researchers measure

Primary outcomes

  1. Sun protection methods

    A presentation consisting of WHO and AAP recommendations will be given and to measure the increase in knowledge and awareness of healthcare professionals, the Skin Cancer and Sun Knowledge scale will be measured at baseline, at the end of the presentation and after 3 months. An increase in the total score indicates an increase in knowledge and awareness.

    Time frame: Baseline and up to 3rd months.

07

Study locations

1 site
08

References and documents

Publications

  • Day AK, Wilson C, Roberts RM, Hutchinson AD. The Skin Cancer and Sun Knowledge (SCSK) Scale: Validity, Reliability, and Relationship to Sun-Related Behaviors Among Young Western Adults. Health Educ Behav. 2014 Aug;41(4):440-8. doi: 10.1177/1090198114529129. Epub 2014 Apr 10. PubMed 24722215 ↗
  • Green AC, Wallingford SC, McBride P. Childhood exposure to ultraviolet radiation and harmful skin effects: epidemiological evidence. Prog Biophys Mol Biol. 2011 Dec;107(3):349-55. doi: 10.1016/j.pbiomolbio.2011.08.010. Epub 2011 Sep 3. PubMed 21907230 ↗
  • Araujo FM, Carmo JAD, Cunha LD, Martins IML, Gon ADS, Caldeira AP. Development and validation of an instrument to assess the knowledge of general practitioners and pediatricians about photoprotection and solar radiation. An Bras Dermatol. 2019 Sep-Oct;94(5):532-541. doi: 10.1016/j.abd.2019.09.011. Epub 2019 Sep 30. PubMed 31777353 ↗
  • Balk SJ. Sun Protection. Pediatr Rev. 2023 Apr 1;44(4):236-239. doi: 10.1542/pir.2022-005545. No abstract available. PubMed 37002351 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06720402
Lead sponsor
Marmara University
Responsible party
Sponsor
First posted
Dec 6, 2024
Start date
May 20, 2024
Primary completion
Dec 31, 2024 (estimated)
Completion
Mar 1, 2025 (estimated)
Last update
Dec 6, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion